Prolonged-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus sickness epizootics.
Ebolavirus (EBOV) has precipitated sickness outbreaks taking tons of of lives, costing billions of {{dollars}} in administration efforts and threatening good ape populations. EBOV ecology should not be completely understood nonetheless contaminated wildlife and consumption of animal carcasses have been linked to human outbreaks, notably inside the Congo Basin.
Partnering with the Congolese Ministry of Nicely being, we carried out wildlife mortality surveillance and educational outreach inside the northern Republic of Congo (RoC). Designed for EBOV detection and to alert public properly being authorities, we established a low-cost wildlife mortality reporting group masking 50 000 km2.
Concurrently, we delivered educational outreach promoting behavioural change to over 6600 people in rural northern RoC. We achieved specimen assortment by teaching enterprise employees on a protected sampling protocol and equipping geographically distributed bases with sampling kits.
We established in-country diagnostics for EBOV testing, reducing diagnostic turnaround time to a few days and demonstrated the absence of EBOV in 58 carcasses. Central Africa stays a high-risk EBOV space, nonetheless RoC, home to crucial remaining populations of good apes, has not had an epidemic since 2005.
This effort continues to function as an untested early warning system in RoC, the place people and good apes have died from earlier Ebola virus sickness outbreaks. This textual content is part of the theme topic ‘Dynamic and integrative approaches to understanding pathogen spillover’.
PSMB8 Antibody |
|||
1-CSB-PA775839 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
PSMB8 Antibody |
|||
E043134 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
1-CSB-PA018886GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
PSMB8 Antibody |
|||
1-CSB-PA018886LA01HU | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
PSMB8 Antibody |
|||
E94054 | EnoGene | 100μg | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E97340 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
PSMB8 Antibody |
|||
E314816 | EnoGene | 100ug/200ul | EUR 295 |
Description: Available in various conjugation types. |
PSMB8 antibody |
|||
70R-13550 | Fitzgerald | 100 ul | EUR 550 |
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
PSMB8 antibody |
|||
70R-19589 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal PSMB8 antibody |
PSMB8 Antibody |
|||
1-CSB-PA116429 | Cusabio |
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
PSMB8 antibody |
|||
BF0434 | Nova Lifetech | 100ug | EUR 355 |
PSMB8 Antibody |
|||
MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 antibody |
|||
MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 Antibody |
|||
MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Antibody |
|||
BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Antibody |
|||
BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
Description: WB,IHC,IF/ICC,ELISA |
PSMB8 Conjugated Antibody |
|||
C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-92394-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
A73468 | EpiGentek | 50 μl | EUR 557 |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
E-AB-61655-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Polyclonal Antibody |
|||
RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
PSMB8 Antibody (N-term) |
|||
MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
×
A novel carbon nanoparticle probe-based ultrasensitive lateral circulation assay for quick detection of Ebola virus.
Ebola virus (EBOV) is an terribly contagious pathogen first present in Africa associated to excessive hemorrhagic sickness in individuals and nonhuman primates, which has resulted in at least 28 500 suspected circumstances and 11 300 confirmed deaths in 2014-2016 Ebola epidemic in West Africa.
Speedy and delicate detection of EBOV is the essential factor to rising the likelihood of survival and reducing an an infection costs in pandemic areas. Proper right here, we report an ultrasensitive and instrument-free EBOV detection assay primarily based totally on colloidal carbon immunochromatography.
Carbon nanoparticle-labeled rabbit anti-EBOV-VP40 IgG had been concentrated inside the conjugate pad, monoclonal antibody (McAb, 4B7F9) in the direction of EBOV-VP40 and goat anti-rabbit IgG had been immobilized on the nitrocellulose membrane with 2 μL/cm at a spotlight of 1 mg/mL as check out and administration strains, respectively.
Then the sample software program pad, conjugate launch pad, nitrocellulose membrane and absorbent pad had been assembled proper right into a lateral circulation check out strip.
The check out strip reveals strong specificity in the direction of related viruses that share comparable medical indicators and geographic fluctuate with EBOV, along with marburg virus, influenza virus, yellow fever virus and dengue virus. In addition to, 1 500 damaging serums had been examined with false-positive value of 1.3‰ which significantly lower than that of ReEBOV™ colloidal gold check out bundle helpful by World Nicely being Group (WHO).
The sensitivity of this strip was analyzed using inactivated EBOV with detection prohibit of 100 ng/mL (10⁶ copies/mL) which clearly elevated than that of ReEBOV™ dipstick (10⁸ copies/mL). Furthermore, the strip confirmed wonderful thermal stability traits in room temperature and is likely to be as a point-of-care (POC), ultra-sensitive and specific promising candidate for EBOV serological screening in rural Africa or entry/exit ports.
A Survey of Virus Recombination Uncovers Canonical Choices of Artificial Chimeras Generated All through Deep Sequencing Library Preparation.
Chimeric reads could also be generated by in vitro recombination all through the preparation of high-throughput sequencing libraries.
Our attempt to detect natural recombination between the genomes of dengue virus (DENV; +ssRNA genome) and its mosquito host using the Illumina Nextera sequencing library preparation bundle revealed that almost all, if not all, detected host-virus chimeras had been artificial.
Definitely, these chimeras weren’t further frequent than with administration RNA from one different species (a pillbug), which was certainly not in contact with DENV RNA earlier to the library preparation.
The proportion of chimera varieties merely mirrored these of the three species amongst sequencing reads. Chimeras had been repeatedly characterised by the presence of 1-20 bp microhomology between recombining fragments.
Inside-species chimeras principally involved fragments in reverse orientations and located decrease than 100 bp from each other inside the parental genome.
We found comparable choices in printed datasets using two totally different viruses: Ebola virus (EBOV; -ssRNA genome) and a herpesvirus (dsDNA genome), every produced with the Illumina Nextera protocol. These canonical choices counsel that artificial chimeras are generated by intra-molecular template switching of the DNA polymerase all through the PCR step of the Nextera protocol.
Lastly, a broadcast Illumina dataset using the Flock Residence virus (FHV; +ssRNA genome) generated with a protocol stopping artificial recombination revealed the presence of 1-10 bp microhomology motifs in FHV-FHV chimeras, nonetheless just a few recombining fragments had been in reverse orientations.
Our analysis uncovered sequence choices characterizing recombination breakpoints in short-read sequencing datasets, which can be helpful to guage the presence and extent of artificial recombination.
Influenza A (A / Brisbane / 10 / 07) H3N2 Protein |
|||
abx060621-50g | Abbexa | 50 µg | Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
7-07948 | CHI Scientific | 10µg | Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
7-07949 | CHI Scientific | 50µg | Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
7-07950 | CHI Scientific | 1mg | Ask for price |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
MBS143232-001mg | MyBiosource | 0.01mg | EUR 240 |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
MBS143232-005mg | MyBiosource | 0.05mg | EUR 310 |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
MBS143232-1mg | MyBiosource | 1mg | EUR 2375 |
Influenza A Virus H3N2 Brisbane 10/07 |
|||
MBS143232-5x1mg | MyBiosource | 5x1mg | EUR 10370 |
H3N2 Influenza-A Virus Brisbane 10/07 |
|||
rAP-5410 | Angio Proteomie | Inquiry | Ask for price |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
|||
20-abx260509 | Abbexa |
|
|
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
|||
abx260509-10g | Abbexa | 10 µg | EUR 325 |
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
|||
abx260509-2g | Abbexa | 2 µg | EUR 225 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen |
|||
11-567 | ProSci | 0.1 mg | EUR 632.4 |
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2) |
Influenza A Strain A/Brisbane/10/07 (H3N2) Protein |
|||
GWB-T00035 | GenWay Biotech | 1mg | Ask for price |
Influenza A (A/Brisbane/10/06) |
|||
MBS318591-1mg | MyBiosource | 1mg | EUR 1895 |
Influenza A (A/Brisbane/10/06) |
|||
MBS318591-5x1mg | MyBiosource | 5x1mg | EUR 8355 |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
|||
IFLUABN1007H3N2ALR100UG | Innovative research | each | EUR 738 |
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid |
|||
MBS8431003-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
|||
MBS8114355-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
|||
MBS8114355-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
|||
MBS8114357-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
|||
MBS8114357-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza A, Brisbane 10/06 (H3N2) |
|||
MBS655118-1mg | MyBiosource | 1mg | EUR 1690 |
Influenza A, Brisbane 10/06 (H3N2) |
|||
MBS655118-5x1mg | MyBiosource | 5x1mg | EUR 7460 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
|||
MBS8114356-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
|||
MBS8114356-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Insect Cell Lysate (WB positive control) |
|||
MBS8119887-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Influenza A H1N1 (A/Brisbane/02/2018) Nucleoprotein/NP Insect Cell Lysate (WB positive control) |
|||
MBS8119889-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
|||
MBS8114342-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
|||
MBS8114342-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza B (B/Brisbane/60/2008) Nucleoprotein/NP Insect Cell Lysate (WB positive control) |
|||
MBS8119895-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
|||
MBS8115772-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cell Lysate (WB positive control) |
|||
MBS8115772-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
|||
MBS8115774-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control) |
|||
MBS8115774-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
|||
MBS8114341-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
|||
MBS8114341-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza B (B/Brisbane/3/2007) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control) |
|||
MBS8116043-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza B (B/Brisbane/3/2007) Hemagglutinin/HA1 HEK293 Cell Lysate (WB positive control) |
|||
MBS8116043-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant |
|||
rAP-5428 | Angio Proteomie | Inquiry | Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag |
|||
E40VAG023 | EnoGene | 20ug | EUR 495 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
|||
MBS8115773-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza B (B/Brisbane/60/2008) Hemagglutinin (HA1 Subunit) HEK293 Cell Lysate (WB positive control) |
|||
MBS8115773-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza A virus H3N2 (Brisbane) Antigen |
|||
VAC-0271 | Creative BioMart | 0.5ml | EUR 1598.4 |
Description: Protein |
Influenza virus B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cells Cell Lysate (WB positive control) |
|||
MBS8115775-03mg | MyBiosource | 0.3mg | EUR 280 |
Influenza virus B (B/Brisbane/60/2008) Hemagglutinin/HA Insect Cells Cell Lysate (WB positive control) |
|||
MBS8115775-5x03mg | MyBiosource | 5x0.3mg | EUR 1205 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set |
|||
ABPR-ZB267 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
Description: Quantitative determination of Influenza Hemagglutinin |
H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant |
|||
rAP-5423 | Angio Proteomie | Inquiry | Ask for price |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
|||
MBS8118343-15Plates | MyBiosource | 15Plates | EUR 800 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
|||
MBS8118343-5Plates | MyBiosource | 5Plates | EUR 450 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set |
|||
MBS8118343-5x15Plates | MyBiosource | 5x15Plates | EUR 3695 |
Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag |
|||
E40VAG022 | EnoGene | 20ug | EUR 495 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP) |
|||
MBS6481610-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP) |
|||
MBS6481610-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE) |
|||
MBS6481620-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE) |
|||
MBS6481620-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag |
|||
E40VAG011 | EnoGene | 20ug | EUR 495 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC) |
|||
MBS6481611-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC) |
|||
MBS6481611-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP) |
|||
MBS6481614-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP) |
|||
MBS6481614-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC) |
|||
MBS6481613-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC) |
|||
MBS6481613-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
|||
MBS8104742-002mL | MyBiosource | 0.02mL | EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
|||
MBS8104742-01mL | MyBiosource | 0.1mL | EUR 365 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb |
|||
MBS8104742-5x01mL | MyBiosource | 5x0.1mL | EUR 1490 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104746-002mL | MyBiosource | 0.02mL | EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104746-01mL | MyBiosource | 0.1mL | EUR 385 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104746-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104747-002mL | MyBiosource | 0.02mL | EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104747-01mL | MyBiosource | 0.1mL | EUR 385 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104747-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104748-002mL | MyBiosource | 0.02mL | EUR 185 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104748-01mL | MyBiosource | 0.1mL | EUR 385 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb |
|||
MBS8104748-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (Biotin) |
|||
MBS6481612-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (Biotin) |
|||
MBS6481612-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
11-563 | ProSci | 0.05 mg | EUR 632.4 |
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
11-564 | ProSci | 0.05 mg | EUR 632.4 |
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (HRP), Mouse MAb |
|||
MBS8104743-01mg | MyBiosource | 0.1mg | EUR 440 |
Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (HRP), Mouse MAb |
|||
MBS8104743-5x01mg | MyBiosource | 5x0.1mg | EUR 1820 |
Influenza B- Virus Brisbane 60/2008 Recombinant |
|||
rAP-5434 | Angio Proteomie | Inquiry | Ask for price |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 405) |
|||
MBS6481615-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 405) |
|||
MBS6481615-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 490) |
|||
MBS6481616-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 490) |
|||
MBS6481616-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 550) |
|||
MBS6481617-01mL | MyBiosource | 0.1mL | EUR 1090 |
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 550) |
|||
MBS6481617-5x01mL | MyBiosource | 5x0.1mL | EUR 4765 |
×
Tagsrecombinant proteins biotechnology recombinant proteins definition recombinant proteins drug recombinant proteins examples recombinant proteins ppt recombinant proteins production recombinant proteins sds page gel recombinant proteins technology test kits test kits cdc test kits contaminated test kits contaminated uk test kits contaminated with coronavirus test kits contaminated with covid-19 test kits contaminated with covid19 test kits fda test kits for baquacil pools test kits for covid-19 test kits for ionizer systems test kits for mdma test kits for meth test kits for mold test kits for molly test kits for nursing homes test kits for ph test kits ny test kits usa